Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 5Dermatologic 4Other hematologic neoplasm 3Gynecologic 3Genitourinary 3Breast 3Gastrointestinal 2Thoracic 1Other solid neoplasm 1Other neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Carcinoma, Hepatocellular 2

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 765Gemcitabine 651Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 441Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 218pembrolizumab 206Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 181Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Laser Therapy × Gastrointestinal × Clear all
NCT01507064 2017-03-07

LANEX

Cardarelli Hospital

Phase 2 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00825669 2016-04-01

Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡